Hirano H, Urist M R
UCLA Bone Research Laboratory, Rehabilitation Center 90024.
Clin Orthop Relat Res. 1991 Feb(263):113-20.
Biopsy specimens of mature trabecular bone from tumors of two typical cases of pseudomalignant heterotopic ossification (PHO; myositis ossificans circumscripta) were transplanted into athymic nude mice. Specimens of normal metaphyseal bone in adjacent areas were also transplanted in the contralateral hindquarter muscles for controls. By seven days, control bone transplants were necrotic and enveloped in granulation tissues whereas PHO transplants were surrounded by proliferating connective tissue derived from the host-bed muscle tissues. In the intervals from 14 and 21 days, the PHO transplants showed vascular and hypertrophied connective-tissue proliferation with appositional deposits of new bone. The microscopic features of the new bone suggested that it was of mouse host-bed origin because the new bone from Case 1, a female, showed nuclei without sex chromatin. The quantities of new bone were measured by correlated histomorphometric and computer image analysis of microradiographs. Little or no cartilage development was noted at any stage. The normal control trabecular bone tissue was slowly resorbed by macrophages and mononuclear phagocytes; multinucleated giant cells were few and relatively small. Except in one questionably small area of one transplant, nontumorous undemineralized normal human bone failed to induce bone formation within the 28-day period of observation. The quantity of new bone formed in athymic mice in response to implants of PHO, estimated from equivalent quantities of bone developed from implants of lyophilized matrix-free bone morphogenetic protein (BMP) was about 1 microgram/g of wet PHO tumor weight. Although circumstantial evidence implicates BMP in the pathogenesis of heterotopic ossification, more research should be directed toward regional and systemic factors inhibiting bone development in normal and abnormal conditions, including malignant bone tumors.
将两例典型假性恶性异位骨化(PHO;局限性骨化性肌炎)肿瘤的成熟小梁骨活检标本移植到无胸腺裸鼠体内。相邻区域的正常干骺端骨标本也移植到对侧后肢肌肉中作为对照。到第7天时,对照骨移植坏死,被肉芽组织包裹,而PHO移植被源自宿主床肌肉组织的增殖性结缔组织包围。在14天至21天期间,PHO移植显示血管和肥大的结缔组织增殖,并伴有新骨的贴壁沉积。新骨的微观特征表明它源自小鼠宿主床,因为来自病例1(一名女性)的新骨显示细胞核无性染色质。通过对微射线照片进行相关组织形态计量学和计算机图像分析来测量新骨的量。在任何阶段均未观察到软骨发育。正常对照小梁骨组织被巨噬细胞和单核吞噬细胞缓慢吸收;多核巨细胞数量少且相对较小。除了一个移植中有一个可疑的小区域外,在28天的观察期内,非肿瘤性未脱钙的正常人类骨未能诱导骨形成。根据冻干无基质骨形态发生蛋白(BMP)植入物产生的等量骨估计,无胸腺小鼠对PHO植入物产生反应而形成的新骨量约为1微克/克湿PHO肿瘤重量。尽管间接证据表明BMP与异位骨化的发病机制有关,但更多的研究应针对在正常和异常情况下抑制骨发育的局部和全身因素,包括恶性骨肿瘤。